Last updated on March 2019

Are you suffering from lupus? Are you not responding to your current treatment?

Other Details:

What will happen during the study?

The study is made up of three parts:

  • Part 1: Screening – if you are interested in taking part, you will be invited to attend a screening visit up to 6 weeks before study treatment begins. During this visit, you will undergo medical tests and examinations to determine whether you qualify for the study.

  • Part 2: Double-blind treatment period – If you qualify, you will be asked to return to the study clinic every 4 weeks for 52 weeks (14 visits in total). During these visits, you will undergo further tests and receive the study drug. ‘Double-blind’ means that neither you nor the study staff knows which study drug you are taking.

  • Part 3: Extension period – you may be able to join the extension period, during which you will receive the investigational drug and visit the study clinic every 24 weeks over 104 weeks (5 or 6 visits in total).

    Contact Investigators or Research Sites near you

    Start Over

    Steven Hernandez

    New Horizon Research Center
    Miami, FL United States
      Connect »
  • Recruitment Status: Open

    Brief Description Eligibility Contact Research Team

    Receive Emails About New Clinical Trials!

    Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.